Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Renhe Capital is a asset management company.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
1/2016 | Mingde Bio | Private Equity Round | - |
1/2022 | UWLaser | Post-IPO Equity | - |
1/2016 | H&a;R Century | Post-IPO Equity | - |
12/2013 | HUNAN TEA GROUP CO.,LTD | Series A | 1.6M |
3/2016 | Renren | Post-IPO Equity | - |
11/2016 | ACCB Biotech | Venture Round | - |
7/2018 | Hainan Wensheng New Material Technology | Venture Round | - |
1/2016 | Bay Environmental Technology (Bayeco) | Venture Round | - |
1/2016 | Junmeng Game Online Game Industry | Private Equity Round | - |
1/2016 | Tiansheng Pharmaceutical Group Co Ltd | Private Equity Round | - |
8/2021 | Anrei Medical | Private Equity Round | - |
1/2016 | Biomarker Technologies | Private Equity Round | - |
5/2018 | Orbbec | Series D | 200M |
11/2016 | Inno Laser Technology | Venture Round | - |
1/2016 | Kawin Technology | Venture Round | - |
7/2016 | Kuai CTO | Angel Round | 0 |
1/2016 | Waluer | Private Equity Round | - |
1/2013 | Medicilon | Series B | 3.2M |
12/2021 | Zhengzheng Medicine | Series B | - |
2/2017 | Yitongwen | Private Equity Round | - |
7/2012 | Dream | Series B | 3.1M |
6/2015 | Biomarker Technologies | Series B | 16.2M |
12/2021 | Zezheng Pharmaceutical | Series B | 15.7M |
8/2018 | Kangso Medical Inspection | Series A | 2.9M |
1/2022 | UWLaser | Post-IPO Equity | - |
12/2021 | Zezheng Pharmaceutical | Series B | 0 |
12/2021 | Zhengzheng Medicine | Series B | - |
8/2021 | Anrei Medical | Private Equity Round | - |
8/2018 | Kangso Medical Inspection | Series A | 0 |
7/2018 | Hainan Wensheng New Material Technology | Venture Round | - |
5/2018 | Orbbec | Series D | 0 |
2/2017 | Yitongwen | Private Equity Round | - |
11/2016 | ACCB Biotech | Venture Round | - |
11/2016 | Inno Laser Technology | Venture Round | - |
Name | Price |
---|
Name | Size | Announced Date |
---|